J. Ferlay, Cancer Incidence and Mortality Worldwide: IARC CancerBase No, 2012.

A. Noone, Cancer Statistics Review, 1975.

P. Tomasini, EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer, Int J Mol Sci, vol.17, p.2132, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01477442

J. S. Barnholtz-sloan, Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System, J Clin Oncol, vol.22, pp.2865-2872, 2004.

Y. Oh, Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases, Cancer, vol.115, pp.2930-2938, 2009.

F. Barlesi, Management of brain metastases for lung cancer patients, Bull Cancer, vol.100, pp.303-308, 2013.

P. Métellus, Place of surgery in brain metastases, Bull Cancer, vol.100, pp.51-56, 2013.

E. Tabouret, Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors, Anticancer Res, vol.33, pp.2159-2167, 2013.

S. Villà, Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study, Radiat Oncol, vol.6, p.23, 2011.

C. A. Klein, Parallel progression of primary tumours and metastases, Nat Rev Cancer, vol.9, pp.302-312, 2009.

V. P. Collins, R. K. Loeffler, and H. Tivey, Observations on growth rates of human tumors, Am J Roentgenol Radium Ther Nucl Med, vol.76, 1956.

G. Gundem, The evolutionary history of lethal metastatic prostate cancer, Nature, vol.520, pp.353-357, 2015.

L. Weiss, Patterns of Metastasis, Cancer Metastasis Rev, vol.19, pp.281-301, 2000.

E. V. Sugarbaker, M. Cohen, and . Ketcham, Do metastases metastasize?

, Ann Surg, vol.174, pp.161-167, 1971.

A. F. Chambers, A. C. Groom, and I. C. Macdonald, Dissemination and growth of cancer cells in metastatic sites, Nat Rev Cancer, vol.2, pp.563-572, 2002.

, Cancer Growth and Metastasis. PLoS One, vol.7, p.34637, 2012.

J. G. Scott, P. Gerlee, D. Basanta, and A. G. Fletcher, Mathematical modeling of the metastatic process, Experimental Metastasis: Modeling and Analysis

A. Malek, , 2013.

N. Hartung, Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice, Cancer Res, vol.74, pp.6397-6407, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01107681

E. Baratchart, Computational Modelling of Metastasis Development in Renal Cell Carcinoma, PLoS Comput Biol, vol.11, p.1004626, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01164834

S. Benzekry, Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach, Cancer Res, vol.76, pp.535-547, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01222046

J. T. Poleszczuk, Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions, Cancer Res, vol.76, pp.1009-1018, 2016.

D. Barbolosi, A. Benabdallah, F. Hubert, and F. Verga, Mathematical and numerical analysis for a model of growing metastatic tumors, Math Biosci, vol.218, pp.1-14, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00262335

S. Benzekry, Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis, J Evol Equ, vol.11, pp.187-213, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00516693

S. Benzekry, Mathematical and numerical analysis of a model for antiangiogenic therapy in metastatic cancers, ESAIM, Math Model Numer Anal, vol.46, pp.207-237, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00518110

J. G. Reiter, Minimal functional driver gene heterogeneity among untreated metastases, Science, vol.361, pp.1033-1037, 2018.

L. Hanin and J. Rose, Uncovering the natural history of cancer from postmortem cross-sectional diameters of hepatic metastases, Math Med Biol, vol.33, pp.397-416, 2016.

S. Valastyan and R. A. Weinberg, Tumor metastasis: molecular insights and evolving paradigms, Cell, vol.147, pp.275-92, 2011.

S. Friberg and S. Mattson, On the growth rates of human malignant tumors: implications for medical decision making, J Surg Oncol, vol.65, pp.284-297, 1997.

A. K. Laird, Dynamics of Tumour Growth: Comparison of Growth Rates and Extrapolation of Growth Curve To One Cell, Br J Cancer, vol.19, pp.278-91, 1965.

L. Norton, A Gompertzian model of human breast cancer growth, Cancer Res, vol.48, pp.7067-7071, 1988.

S. Benzekry, Classical mathematical models for description and prediction of experimental tumor growth, PLoS Comput Biol, vol.10, p.1003800, 2014.

F. C. Detterbeck and C. J. Gibson, Turning gray: the natural history of lung cancer over time, J Thorac Oncol, vol.3, pp.781-792, 2008.

A. Mujoomdar, Clinical Predictors of Metastatic Disease to the Brain from Non-Small Cell Lung Carcinoma: Primary Tumor Size, Cell Type, and Lymph Node Metastases1, Radiology, vol.242, pp.882-888, 2007.

M. V. Patrone, J. L. Hubbs, J. E. Bailey, and L. B. Marks, How long have I had my cancer, doctor? Estimating tumor age via Collins' law, Oncology, vol.25, pp.38-43, 2011.

L. Norton, T. A. Gilewski, and . Cytokinetics, , 2010.

D. Barbolosi, Modélisation du risque d'évolution métastatique chez les patients supposés avoir une maladie localisée, Oncologie, vol.13, pp.528-533, 2011.

L. Claret, Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics, J Clin Oncol, vol.27, pp.4103-4108, 2009.

J. A. Aguirre-ghiso, How dormant cancer persists and reawakens, Science, vol.361, pp.1314-1315, 2018.

G. P. Gupta and J. Massagué, Cancer metastasis: building a framework, Cell, vol.127, pp.679-695, 2006.

B. Wang, Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC, Clin Neurol Neurosurg, vol.160, pp.96-100, 2017.

G. Han, A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis, Oncotarget, vol.7, pp.56998-57010, 2016.

L. Hanin, K. Seidel, and D. Stoevesandt, A "universal" model of metastatic cancer, its parametric forms and their identification: what can be learned from sitespecific volumes of metastases, J Math Biol, vol.72, pp.1633-1662, 2016.

W. D. Dewys, A Quantitative Model for the Study of the Growth and Treatment of a Tumor and Its Metastases with Correlation between Proliferative State and Sensitivity to Cyclophosphamide, Cancer Res, pp.367-373, 1972.

L. Norton and J. Massagué, Is cancer a disease of self-seeding, Nat Med, vol.12, pp.875-878, 2006.

S. Benzekry, C. Lamont, D. Barbolosi, L. Hlatky, and P. Hahnfeldt,

, Mathematical Modeling of Tumor-Tumor Distant Interactions Supports a Systemic Control of Tumor Growth, Cancer Res, vol.77, pp.5183-5193, 2017.

S. Benzekry, A. Gandolfi, and P. Hahnfeldt, Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis, PLoS One, vol.9, pp.84249-84260, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00868592

D. Imbs, Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non-Small Cell Lung Carcinoma, CPT Pharmacometrics Syst Pharmacol, vol.7, pp.42-50, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01624423

R. Serre, Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy, Cancer Res, vol.76, pp.4931-4940, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01336779

K. Shedden, Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study, Nat Med, vol.14, pp.822-827, 2008.

H. J. Aerts, Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach, Nat Commun, vol.5, p.4006, 2014.

J. S. Spratt, J. S. Meyer, and J. A. Spratt, Rates of growth of human solid neoplasms: Part I, J Surg Oncol, vol.60, pp.137-146, 1995.

S. Benzekry, Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine, Semin Cancer Biol, vol.35, pp.53-61, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01195547

C. L. Chaffer and R. A. Weinberg, A perspective on cancer cell metastasis, Science, vol.331, pp.1559-1564, 2011.

J. W. Baish and R. K. Jain, Cancer, angiogenesis and fractals, Nat Med, vol.4, pp.984-984, 1998.

C. Gomez and N. Hartung, Stochastic and Deterministic Models for the

, Metastatic Emission Process: Formalisms and Crosslinks, Cancer Systems Biology 193-224, 2018.

T. Mathworks, Matlab with statistics and optimization toolboxes, 2015.

G. A. Seber and C. J. Wild, Nonlinear regression, 2003.

[. References and . Arai, Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group, Jpn J Clin Oncol, vol.24, issue.4, pp.199-204, 1994.

. Detterbeck, F. C. Gibson-;-detterbeck, and C. J. Gibson, Turning gray: the natural history of lung cancer over time, J Thorac Oncol, vol.3, issue.7, pp.781-792, 2008.

. Friberg, S. Mattson-;-friberg, and S. Mattson, On the growth rates of human malignant tumors: implications for medical decision making, J Surg Oncol, vol.65, issue.4, pp.284-297, 1997.

[. Garland, The rate of growth and apparent duration of untreated primary bronchial carcinoma, Cancer, vol.16, pp.694-707, 1963.

D. M. Geddes, The natural history of lung cancer: a review based on rates of tumour growth, Br J Dis Chest, vol.73, issue.1, pp.1-17, 1979.

[. Jennings, Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements, Radiology, issue.2, pp.554-563, 2006.

[. Mizuno, Comparison of actual survivorship after treatment with survivorship predicted by actual tumor-volume doubling time from tumor diameter at first observation, Cancer, vol.53, issue.12, pp.2716-2720, 1984.

M. Schwartz and . Spratt, The frequency distribution of the rates of growth and the estimated duration of primary pulmonary carcinomas, Cancer, vol.14, pp.687-693, 1961.

J. S. Spratt and T. L. Spratt, Rates of growth of pulmonray metastases and host survival, Ann Surg, vol.159, issue.2, pp.161-171, 1964.

[. Usuda, Tumor doubling time and prognostic assessment of patients with primary lung cancer, Cancer, vol.74, issue.8, pp.2239-2244, 1994.

W. Weiss, Tumor doubling time and survival of men with bronchogenic carcinoma, Chest, vol.65, issue.1, pp.3-8, 1974.